A new drug that could prevent old age blindness is being developed, according to researchers.
'Lucentis', the drug that is being designed to combat the wet type of Age-related Macular Degeneration (AMD), has the potential to prevent blindness in several people, while helping many others to regain their lost vision.
According to a study published in the New England Journal of Medicine, Lucentis has prevented vision loss in 90% of the patients studied. A remarkable improvement in vision was reported in 33% of those experimented on . 716 patients, who formed the subject of the clinical study, received an injection of the drug every month for two years.
This is for the first time that a drug that is used in the treatment of AMD, has been found capable of improving vision. The drug is due to obtain license in Europe by the end of this year.